In this episode of Healthcare Americana, host Christopher Habig is joined by Dr. Anthony DiGiorgio. Together, they explore the 340B Drug Discount Program, a federal initiative meant to help low-income patients access affordable medications. They reveal how the program has shifted over time to prioritize large healthcare institutions, creating unintended consequences like inflated healthcare costs and reduced patient access to discounts. The conversation calls for greater transparency and reforms to ensure the program supports those it was designed for. By addressing these challenges and realigning the program with its original mission, the healthcare system can better serve patients and create a more equitable and efficient model of care.
More on Freedom Healthworks & FreedomDoc
Subscribe at https://healthcareamericana.com/
More on Dr. Anthony DiGiorgio
Popular Podcasts
On Purpose with Jay Shetty
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.